Emmanuel N Lazaridis

Summary

Affiliation: International Agency for Research on Cancer
Country: France

Publications

  1. ncbi request reprint A simple method to improve probe set estimates from oligonucleotide arrays
    Emmanuel N Lazaridis
    H Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, MRC CANCONT Tampa, FL 33612 9497, USA
    Math Biosci 176:53-8. 2002
  2. ncbi request reprint Introduction to microarray experimentation and analysis
    Peter Gieser
    Net Impact, Inc, Temecula, CA, USA
    Methods Mol Biol 184:29-49. 2002
  3. ncbi request reprint Gene expression profiling and subgroup identification of oligodendrogliomas
    Herve Huang
    International Agency for Research on Cancer IARC, 150 cours Albert Thomas, F 69372 Lyon Cedex 08, France
    Oncogene 23:6012-22. 2004

Collaborators

  • Richard Jove
  • H Ohgaki
  • Herve Huang
  • Peter Gieser
  • Frank L Heppner
  • Yoshikazu Okamoto
  • Anne Jouvet
  • Paul Kleihues
  • Anne Vital
  • Hideaki Yokoo
  • Yasuhiro Yonekawa
  • Michelle Fevre-Montange
  • Gregory C Bloom

Detail Information

Publications3

  1. ncbi request reprint A simple method to improve probe set estimates from oligonucleotide arrays
    Emmanuel N Lazaridis
    H Lee Moffitt Cancer Center and Research Institute, University of South Florida, 12902 Magnolia Drive, MRC CANCONT Tampa, FL 33612 9497, USA
    Math Biosci 176:53-8. 2002
    ..We illustrate this approach using data from our study seeking a molecular fingerprint of STAT3 regulated genes for early detection of human cancer...
  2. ncbi request reprint Introduction to microarray experimentation and analysis
    Peter Gieser
    Net Impact, Inc, Temecula, CA, USA
    Methods Mol Biol 184:29-49. 2002
  3. ncbi request reprint Gene expression profiling and subgroup identification of oligodendrogliomas
    Herve Huang
    International Agency for Research on Cancer IARC, 150 cours Albert Thomas, F 69372 Lyon Cedex 08, France
    Oncogene 23:6012-22. 2004
    ..048). These results demonstrate that oligodendrogliomas and low-grade astrocytomas differ in their gene expression profiles, and that there are subgroups of oligodendroglioma with distinct expression profiles related to clinical outcome...